Wordt geladen...
Tumor-Agnostic Drug Development
Therapies designed to target cancers that harbor specific molecular signatures have reshaped the landscape of oncologic drug development, and advances in next generation sequencing have led to an increase in the identification of these alterations across tumor types. Tumor-agnostic trial designs, su...
Bewaard in:
| Gepubliceerd in: | Am Soc Clin Oncol Educ Book |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7506519/ https://ncbi.nlm.nih.gov/pubmed/30231313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EDBK_200831 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|